Exact Mass: 380.1351
Exact Mass Matches: 380.1351
Found 234 metabolites which its exact mass value is equals to given mass value 380.1351,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-O-Methylglycyrol
14-hydroxy-3,5-dimethoxy-4-(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one
3-O-Methylglycyrol is found in root vegetables. 3-O-Methylglycyrol is isolated from Glycyrrhiza species roots. Isolated from Glycyrrhiza subspecies roots. 3-O-Methylglycyrol is found in root vegetables.
2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one
2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one
2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one is found in citrus. 2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one is a constituent of the fruits of tangerine (Citrus reticulata cv. blanco). Constituent of the fruits of tangerine (Citrus reticulata cv. blanco). 2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b]dipyran-4-one is found in citrus.
N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulphanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Amosulalol
5-(1-hydroxy-2-{[2-(2-methoxyphenoxy)ethyl]amino}ethyl)-2-methylbenzene-1-sulfonamide
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Egtazic acid
2-[2-[2-[2-[Bis(carboxymethyl)amino]ethoxy]ethoxy]ethyl-(carboxymethyl)amino]acetate
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
4-[[2-(2-Acetylsulfanylethyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl]oxy]-4-oxobutanoic acid
4-({2-[2-(acetylsulfanyl)ethyl]-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl}oxy)-4-oxobutanoic acid
Varespladib
2-{[1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl]oxy}acetic acid
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
Vellokaempferol 3,4-dimethyl ether
5-Hydroxy-3,4-dimethoxy-5"-isopropenyl-4",5"-dihydrofurano [ 2,3:7,6 ] flavone
Ovalichromene A
(S) -2- (1,3-Benzodioxol-5-yl) -2,3-dihydro-6-methoxy-8,8-dimethyl-4H,8H-benzo [ 1,2-b:3,4-b ] dipyran-4-one
3,4-Methylenedioxy-2-methoxy-6,6-dimethlchromeno-[2,3:4,3]-beta-hydroxychalcone
3,4-Methylenedioxy-2-methoxy-6,6-dimethlchromeno-[2,3:4,3]-beta-hydroxychalcone
Indicanine A
4-Hydroxy-5,4-dimethoxy-5-(1-methylethenyl)-4,5-dihydrofurano[2,3:7,6]-3-phenylcoumarin
Robustic acid
4-Hydroxy-5-methoxy-3- (4-methoxyphenyl) -8,8-dimethyl-2H,8H-benzo [ 1,2-b:5,4-b ] dipyran-2-one
Muxiangrin II
5-Hydroxy-2-(8-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-7-methoxy-6-methyl-4H-1-benzopyran-4-one
Millettocalyxin B
2- (1,3-Benzodioxol-5-yl) -7-methoxy-6- [ (3-methyl-2-butenyl) oxy ] -4H-1-benzopyran-4-one
Multijuginol
(7aR,10S,10aS) -rel- (+) -7a,9,10,10a-Tetrahydro-10-hydroxy-5-methoxy-9,9-dimethyl-2-phenyl-4H-furo [ 3,2:4,5 ] furo [ 2,3-h ] -1-benzopyran-4-one
7-Prenyloxy-8-methoxy-3,4-methylenedioxyisoflavone
7-Prenyloxy-8-methoxy-3,4-methylenedioxyisoflavone
4-Hydroxy-3,6-dimethoxy-6,6-dimethylpyrano[2,3:7,8]flavone
4-Hydroxy-3,6-dimethoxy-6",6"-dimethylpyrano [ 2,3:7,8 ] flavone
3,7,4-trihydroxy-4-(2,4-dihydroxy-6-methylphenyl)flavan
3,7,4-trihydroxy-4-(2,4-dihydroxy-6-methylphenyl)flavan
(+)-howiinol A|(+)-howiionol A|(1R,2R)-2-hydroxy-2-((2R,3S)-3-hydroxy-6-oxo-3,6-dihydro-2H-pyran-2-yl)-1-phenylethyl cinnamate|howiinol A
(+)-howiinol A|(+)-howiionol A|(1R,2R)-2-hydroxy-2-((2R,3S)-3-hydroxy-6-oxo-3,6-dihydro-2H-pyran-2-yl)-1-phenylethyl cinnamate|howiinol A
1-(2,2-Dimethyl-5-methoxy-2H-1-benzopyran-6-yl)-3-(1,3-benzodioxol-5-yl)propane-1,3-dione
1-(2,2-Dimethyl-5-methoxy-2H-1-benzopyran-6-yl)-3-(1,3-benzodioxol-5-yl)propane-1,3-dione
(5bR,10bR)-5b,10b-dihydro-8-hydroxy-5-methoxy-2,2-dimethyl-2H,11H-benzo[4,5]furo[2,3-d]pyrano[3,2-g]chromene-7-carbaldehyde|gangetial
(5bR,10bR)-5b,10b-dihydro-8-hydroxy-5-methoxy-2,2-dimethyl-2H,11H-benzo[4,5]furo[2,3-d]pyrano[3,2-g]chromene-7-carbaldehyde|gangetial
(2S)-2?,5,7-trihydroxy-6-prenyl-furo[2?,3?:4?,5?]flavanone|cudraflavanone E
(2S)-2?,5,7-trihydroxy-6-prenyl-furo[2?,3?:4?,5?]flavanone|cudraflavanone E
4,5,7-trihydroxy-6-(2-hydroxy-3-methylbut-3-enyl)-2-styrylchromone|platachromone C
4,5,7-trihydroxy-6-(2-hydroxy-3-methylbut-3-enyl)-2-styrylchromone|platachromone C
4,5,7-trihydroxy-8-(2-hydroxy-3-methylbut-3-enyl)-2-styrylchromone|platachromone D
4,5,7-trihydroxy-8-(2-hydroxy-3-methylbut-3-enyl)-2-styrylchromone|platachromone D
1,2-Di-O-acyl-3-O-(6-O-acyl-beta-D-galactopyranosyl)-sn-glycerol
1,2-Di-O-acyl-3-O-(6-O-acyl-beta-D-galactopyranosyl)-sn-glycerol
BIBB 515
1-(4-chlorobenzoyl)-4-[[4-(4,5-dihydro-2-oxazolyl)phenyl]methylene]-piperidine
BIBB 515 is a potent, selective and orally active 2,3-oxidosqualene cyclase (OSC) inhibitor with ED50 values of 0.2-0.5 mg/kg and 0.36-33.3 mg/kg in rats and mice (1-5 hours), respectively. BIBB 515 exerts lipid-lowering effect mainly by inhibiting the production of low-density lipoprotein (LDL)[1].
Ala Cys Ser Thr
(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid
Ala Cys Thr Ser
(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid
Ala Ser Cys Thr
(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid
Ala Ser Thr Cys
(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid
Ala Thr Cys Ser
(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid
Ala Thr Ser Cys
(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid
Cys Ala Ser Thr
(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid
Cys Ala Thr Ser
(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid
Cys Gly Thr Thr
(2S,3R)-2-[(2S,3R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-hydroxybutanamido]-3-hydroxybutanoic acid
Cys Ser Ala Thr
(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]propanamido]-3-hydroxybutanoic acid
Cys Ser Thr Ala
(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]propanoic acid
Cys Thr Ala Ser
(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]propanamido]-3-hydroxypropanoic acid
Cys Thr Gly Thr
(2S,3R)-2-{2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]acetamido}-3-hydroxybutanoic acid
Cys Thr Ser Ala
(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]propanoic acid
Cys Thr Thr Gly
2-[(2S,3R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]acetic acid
Gly Cys Thr Thr
(2S,3R)-2-[(2S,3R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid
Gly Met Ser Ser
(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid
Gly Ser Met Ser
(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid
Gly Ser Ser Met
(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid
Gly Thr Cys Thr
(2S,3R)-2-[(2R)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid
Gly Thr Thr Cys
(2R)-2-[(2S,3R)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid
Met Gly Ser Ser
(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-hydroxypropanamido]-3-hydroxypropanoic acid
Met Ser Gly Ser
(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]acetamido}-3-hydroxypropanoic acid
Met Ser Ser Gly
2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]acetic acid
Ser Ala Cys Thr
(2S,3R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid
Ser Ala Thr Cys
(2R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid
Ser Cys Ala Thr
(2S,3R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]propanamido]-3-hydroxybutanoic acid
Ser Cys Thr Ala
(2S)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]propanoic acid
Ser Gly Met Ser
(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-(methylsulfanyl)butanamido]-3-hydroxypropanoic acid
Ser Gly Ser Met
(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-hydroxypropanamido]-4-(methylsulfanyl)butanoic acid
Ser Met Gly Ser
(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-hydroxypropanoic acid
Ser Met Ser Gly
2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]-3-hydroxypropanamido]acetic acid
Ser Ser Gly Met
(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]acetamido}-4-(methylsulfanyl)butanoic acid
Ser Ser Met Gly
2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-(methylsulfanyl)butanamido]acetic acid
Ser Thr Ala Cys
(2R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]propanamido]-3-sulfanylpropanoic acid
Ser Thr Cys Ala
(2S)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]propanoic acid
Thr Ala Cys Ser
(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid
Thr Ala Ser Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid
Thr Cys Ala Ser
(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]propanamido]-3-hydroxypropanoic acid
Thr Cys Gly Thr
(2S,3R)-2-{2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]acetamido}-3-hydroxybutanoic acid
Thr Cys Ser Ala
(2S)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]propanoic acid
Thr Cys Thr Gly
2-[(2S,3R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]acetic acid
Thr Gly Cys Thr
(2S,3R)-2-[(2R)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-sulfanylpropanamido]-3-hydroxybutanoic acid
Thr Gly Thr Cys
(2R)-2-[(2S,3R)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-hydroxybutanamido]-3-sulfanylpropanoic acid
Thr Ser Ala Cys
(2R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]propanamido]-3-sulfanylpropanoic acid
Thr Ser Cys Ala
(2S)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]propanoic acid
Thr Thr Cys Gly
2-[(2R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]acetic acid
Thr Thr Gly Cys
(2R)-2-{2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]acetamido}-3-sulfanylpropanoic acid
4'-Hydroxy-3,6-dimethoxy-6'',6''-dimethylpyrano[2,3:7,8]flavone
2-(4-Hydroxyphenyl)-3,6-dimethoxy-8,8-dimethyl-4H,8H-benzo[1,2-b:3,4-b']dipyran-4-one
Methyl 4-acetoxy-7-(benzyloxy)-6-methoxy-2-naphthoate
Methyl 4-acetoxy-7-(benzyloxy)-6-methoxy-2-naphthoate
2-aminophthalylhydrazido-n-acetyl-b-d-glucosaminide
2-aminophthalylhydrazido-n-acetyl-b-d-glucosaminide
[4-(4-chloro-phenyl)-piperazin-1-yl]-naphthalen-2-yl-acetic acid
[4-(4-chloro-phenyl)-piperazin-1-yl]-naphthalen-2-yl-acetic acid
N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate
N-tert-butyl-N-[2-[(5-chloro-1,3-benzoxazol-2-yl)-(3-oxobutyl)amino]ethyl]carbamate
XRP44X
1-(3-Chlorophenyl)-4-[(3-methyl-1-phenyl-1H-pyrazol-5-YL)carbonyl]piperazine
XRP44X inhibits Ras-induced transcription activation with the IC50 of 10 nM. XRP44X inhibits activation of the Ras-Erk-1/2 pathway by FGF-2[1]. XRP44X is an inhibitor of Ras/Erk activation of Elk3 that also affects microtubules[2].
1H-Indole,1-[[[4-ethyl-5-(2-furanyl)-4H-1,2,4-triazol-3-yl]thio]acetyl]-2,3-dimethyl-(9CI)
1H-Indole,1-[[[4-ethyl-5-(2-furanyl)-4H-1,2,4-triazol-3-yl]thio]acetyl]-2,3-dimethyl-(9CI)
Biclotymol
4-chloro-2-[(5-chloro-2-hydroxy-6-methyl-3-propan-2-ylphenyl)methyl]-3-methyl-6-propan-2-ylphenol
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
trabodenoson
trabodenoson
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent Trabodenoson (INO-8875), an adenosine mimetic, is a highly selective Adenosine A1 receptor agonist. Trabodenoson (INO-8875) is used in the study for Primary Open-Angle Glaucoma[1].
3(S)-BOC-AMINO-2,3-DIHYDRO-4-OXO-1,5-BENZOTHIAZEPINE-5(2H)-ACETIC ACID ETHYL ESTER
3(S)-BOC-AMINO-2,3-DIHYDRO-4-OXO-1,5-BENZOTHIAZEPINE-5(2H)-ACETIC ACID ETHYL ESTER
Ethanol, 2-[2-(2-phenoxyethoxy)ethoxy]-, 4-methylbenzenesulfonate
Ethanol, 2-[2-(2-phenoxyethoxy)ethoxy]-, 4-methylbenzenesulfonate
4-(3-{[5-(Trifluoromethyl)pyridin-2-Yl]oxy}benzyl)piperidine-1-Carboxylic Acid
4-(3-{[5-(Trifluoromethyl)pyridin-2-Yl]oxy}benzyl)piperidine-1-Carboxylic Acid
Egtazic acid
Egtazic acid
D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D020011 - Protective Agents > D000931 - Antidotes
Cilastatin Sodium
Sodium (Z)-7-(((R)-2-amino-2-carboxyethyl)thio)-2-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoate
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Varespladib
Varespladib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Varespladib (LY315920) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively[1].
Amosulalol
Amosulalol
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
N-(3,4-dimethoxyphenyl)-7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazole-3-carboxamide
N-(3,4-dimethoxyphenyl)-7-methoxy-4,5-dihydrobenzo[g][1,2]benzoxazole-3-carboxamide
N-[1-[(4-fluorophenyl)methyl]-3,5-dimethyl-4-pyrazolyl]-5-(2-furanyl)-3-isoxazolecarboxamide
N-[1-[(4-fluorophenyl)methyl]-3,5-dimethyl-4-pyrazolyl]-5-(2-furanyl)-3-isoxazolecarboxamide
2-(4-Anilinophenoxy)acetic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
2-(4-Anilinophenoxy)acetic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
N-[1-(2-methylpropyl)-3-pyrazolo[3,4-b]quinolinyl]benzenesulfonamide
N-[1-(2-methylpropyl)-3-pyrazolo[3,4-b]quinolinyl]benzenesulfonamide
N-(3-methoxyphenyl)-1,3-dioxo-2-(2-oxolanylmethyl)-5-isoindolecarboxamide
N-(3-methoxyphenyl)-1,3-dioxo-2-(2-oxolanylmethyl)-5-isoindolecarboxamide
1-[5-(5-chloro-2-methylphenyl)-2-furanyl]-N-[4-(4-morpholinyl)phenyl]methanimine
1-[5-(5-chloro-2-methylphenyl)-2-furanyl]-N-[4-(4-morpholinyl)phenyl]methanimine
(3aR,6aS)-3-(3,4-dimethoxyphenyl)-5-(2,4-dimethylphenyl)-3a,6a-dihydropyrrolo[3,4-d]isoxazole-4,6-dione
(3aR,6aS)-3-(3,4-dimethoxyphenyl)-5-(2,4-dimethylphenyl)-3a,6a-dihydropyrrolo[3,4-d]isoxazole-4,6-dione
Ethyl {2-[(4-methylphenyl)amino]-1,3-thiazol-4-yl}(phenylhydrazono)acetate
Ethyl {2-[(4-methylphenyl)amino]-1,3-thiazol-4-yl}(phenylhydrazono)acetate
methyl 2-[4-ethyl-2-methoxy-5-oxo-2-(9H-pyrido[3,4-b]indol-1-yl)furan-3-yl]acetate
methyl 2-[4-ethyl-2-methoxy-5-oxo-2-(9H-pyrido[3,4-b]indol-1-yl)furan-3-yl]acetate
Methyl (9R,12R,21S)-15,20-dioxo-19-oxa-8,16-diazahexacyclo[10.6.4.01,9.02,7.09,21.012,16]docosa-2,4,6,13-tetraene-8-carboxylate
Methyl (9R,12R,21S)-15,20-dioxo-19-oxa-8,16-diazahexacyclo[10.6.4.01,9.02,7.09,21.012,16]docosa-2,4,6,13-tetraene-8-carboxylate
(3S)-5-Bromo-3-(tert-butyldimethylsilyloxy)-1-pivaloyloxypentane
(3S)-5-Bromo-3-(tert-butyldimethylsilyloxy)-1-pivaloyloxypentane
SNS-032 (BMS-387032)
N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Tulrampator
Tulrampator
Tulrampator (S-47445) is an orally active selective AMPA receptor modulator. Tulrampator possesses procognitive, enhancing synaptic plasticity, anti-depressant-anxiolytic-like, procognitive and potential neuroprotective properties. Tulrampator can be used for research of alzheimer’s disease and in major depressive disorder[1][2][3].
(2s,3s,6r,8r)-4-chloro-3-ethenyl-2-isocyano-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(15),4,11,13-tetraene-9,16-dione
(2s,3s,6r,8r)-4-chloro-3-ethenyl-2-isocyano-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(15),4,11,13-tetraene-9,16-dione
1-[(benzoyloxy)methyl]-2-methoxy-7-oxabicyclo[4.1.0]hept-4-en-3-yl benzoate
1-[(benzoyloxy)methyl]-2-methoxy-7-oxabicyclo[4.1.0]hept-4-en-3-yl benzoate
3-(2-hydroxy-4-methoxyphenyl)-5-methoxy-8,8-dimethylpyrano[3,2-g]chromen-4-one
3-(2-hydroxy-4-methoxyphenyl)-5-methoxy-8,8-dimethylpyrano[3,2-g]chromen-4-one
1-(acetyloxy)-3-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)propan-2-yl acetate
1-(acetyloxy)-3-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)propan-2-yl acetate
methyl 3-ethyl-1-formyl-8-methoxy-4-oxo-6h,7h,12h-indolo[2,3-a]quinolizine-2-carboxylate
methyl 3-ethyl-1-formyl-8-methoxy-4-oxo-6h,7h,12h-indolo[2,3-a]quinolizine-2-carboxylate
(2s,3s)-2-[(1r,2r)-1,2-dihydroxy-2-phenylethyl]-6-oxo-2,3-dihydropyran-3-yl (2e)-3-phenylprop-2-enoate
(2s,3s)-2-[(1r,2r)-1,2-dihydroxy-2-phenylethyl]-6-oxo-2,3-dihydropyran-3-yl (2e)-3-phenylprop-2-enoate
(4r,8s)-18-hydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
(4r,8s)-18-hydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
(1r,4s,5r,6s,7r,8s,9s)-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecane-4,5,6-triol
(1r,4s,5r,6s,7r,8s,9s)-9-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecane-4,5,6-triol
(1s,4as,5r,6s,7r)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(1s,4as,5r,6s,7r)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(1r,2s,3r,14s,15s,17s)-15-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁵.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-triene-16,18-dione
(1r,2s,3r,14s,15s,17s)-15-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁵.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-triene-16,18-dione
(2r,3s,4r)-4-(2,4-dihydroxy-6-methylphenyl)-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
(2r,3s,4r)-4-(2,4-dihydroxy-6-methylphenyl)-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
3-(3,4-dimethoxyphenyl)-6-hydroxy-8,8-dimethylpyrano[2,3-h]chromen-4-one
3-(3,4-dimethoxyphenyl)-6-hydroxy-8,8-dimethylpyrano[2,3-h]chromen-4-one
(1s,4ar,5r,6s,7s,7ar)-7-methyl-1-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(1s,4ar,5r,6s,7s,7ar)-7-methyl-1-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(4s,4as,5s,8s,8ar)-8-chloro-8a-hydroxy-3,4a,5-trimethyl-9-oxo-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-4-yl 2-methylbut-2-enoate
(4s,4as,5s,8s,8ar)-8-chloro-8a-hydroxy-3,4a,5-trimethyl-9-oxo-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-4-yl 2-methylbut-2-enoate
(4s,4as,4bs,8s,8as,10ar)-8a-(bromomethyl)-4-hydroxy-8-isopropyl-4,10a-dimethyl-4a,4b,7,8,9,10-hexahydrophenanthren-3-one
(4s,4as,4bs,8s,8as,10ar)-8a-(bromomethyl)-4-hydroxy-8-isopropyl-4,10a-dimethyl-4a,4b,7,8,9,10-hexahydrophenanthren-3-one
(2s)-7-(4-hydroxyphenyl)-4,6-dimethoxy-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(2s)-7-(4-hydroxyphenyl)-4,6-dimethoxy-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
7-(4-hydroxyphenyl)-4,6-dimethoxy-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
7-(4-hydroxyphenyl)-4,6-dimethoxy-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(1s,4as,5r,6s,7s)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(1s,4as,5r,6s,7s)-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
4-[(3,4-dihydroxyphenyl)methyl]-5-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]benzene-1,3-diol
4-[(3,4-dihydroxyphenyl)methyl]-5-[(1e)-2-(4-hydroxy-3-methoxyphenyl)ethenyl]benzene-1,3-diol
(4r,4ar,5r,8s,8as)-4,8-dihydroxy-4a,5,8,8a-tetrahydro-4h-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-5-yl acetate
(4r,4ar,5r,8s,8as)-4,8-dihydroxy-4a,5,8,8a-tetrahydro-4h-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-5-yl acetate
(2s)-5-hydroxy-4-methoxy-6-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
(2s)-5-hydroxy-4-methoxy-6-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
4-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
4-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(1s,4as,5r,6s,7r,7ar)-7-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(1s,4as,5r,6s,7r,7ar)-7-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
18-hydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
18-hydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
4-[(3,4-dihydroxyphenyl)methyl]-5-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]benzene-1,3-diol
4-[(3,4-dihydroxyphenyl)methyl]-5-[2-(4-hydroxy-3-methoxyphenyl)ethenyl]benzene-1,3-diol
(2s)-1-(acetyloxy)-3-{[(2r,3r,4s,5r,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}propan-2-yl acetate
(2s)-1-(acetyloxy)-3-{[(2r,3r,4s,5r,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}propan-2-yl acetate
3-(2h-1,3-benzodioxol-5-yl)-1-(5-hydroxy-7-methoxy-2,2-dimethylchromen-6-yl)prop-2-en-1-one
3-(2h-1,3-benzodioxol-5-yl)-1-(5-hydroxy-7-methoxy-2,2-dimethylchromen-6-yl)prop-2-en-1-one
(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6r,7s,7as)-5,6,7-trihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6r,7s,7as)-5,6,7-trihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
4-chloro-3-ethenyl-2-isocyano-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(15),4,11,13-tetraene-9,16-dione
4-chloro-3-ethenyl-2-isocyano-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(15),4,11,13-tetraene-9,16-dione
1-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-3-(methoxymethyl)naphthalene-2-carbaldehyde
1-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-3-(methoxymethyl)naphthalene-2-carbaldehyde
7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
4,8-dihydroxy-4a,5,8,8a-tetrahydro-4h-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-5-yl acetate
4,8-dihydroxy-4a,5,8,8a-tetrahydro-4h-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-5-yl acetate
4-hydroxy-7,8-dimethoxy-6-(3-methylbut-2-en-1-yl)furo[3,2-b]xanthen-5-one
4-hydroxy-7,8-dimethoxy-6-(3-methylbut-2-en-1-yl)furo[3,2-b]xanthen-5-one
6-[2-(6-hydroxyheptyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboxylic acid
6-[2-(6-hydroxyheptyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboxylic acid
(4s,4as,5s,8s,8ar)-8-chloro-8a-hydroxy-3,4a,5-trimethyl-9-oxo-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-4-yl (2e)-2-methylbut-2-enoate
(4s,4as,5s,8s,8ar)-8-chloro-8a-hydroxy-3,4a,5-trimethyl-9-oxo-4h,5h,6h,7h,8h-naphtho[2,3-b]furan-4-yl (2e)-2-methylbut-2-enoate
8a-(bromomethyl)-4-hydroxy-8-isopropyl-4,10a-dimethyl-4a,4b,7,8,9,10-hexahydrophenanthren-3-one
8a-(bromomethyl)-4-hydroxy-8-isopropyl-4,10a-dimethyl-4a,4b,7,8,9,10-hexahydrophenanthren-3-one
(1r,2r)-2-hydroxy-2-[(2r,3s)-3-hydroxy-6-oxo-2,3-dihydropyran-2-yl]-1-phenylethyl (2e)-3-phenylprop-2-enoate
(1r,2r)-2-hydroxy-2-[(2r,3s)-3-hydroxy-6-oxo-2,3-dihydropyran-2-yl]-1-phenylethyl (2e)-3-phenylprop-2-enoate
(1s,4ar,5r,6s,7r,7ar)-4-methyl-1-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(1s,4ar,5r,6s,7r,7ar)-4-methyl-1-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-4a,5,6,7-tetrol
(s)-[(2r,3r,3as,6as)-3-hydroxy-5-oxo-tetrahydro-2h-furo[3,2-b]furan-2-yl](phenyl)methyl (2e)-3-phenylprop-2-enoate
(s)-[(2r,3r,3as,6as)-3-hydroxy-5-oxo-tetrahydro-2h-furo[3,2-b]furan-2-yl](phenyl)methyl (2e)-3-phenylprop-2-enoate
4-(2,4-dihydroxy-6-methylphenyl)-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
4-(2,4-dihydroxy-6-methylphenyl)-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
6-{2-[(6s)-6-hydroxyheptyl]-1,3-thiazol-4-yl}-4,5-dimethoxypyridine-2-carboxylic acid
6-{2-[(6s)-6-hydroxyheptyl]-1,3-thiazol-4-yl}-4,5-dimethoxypyridine-2-carboxylic acid
4,5-dimethoxy-3,6-bis(4-methoxyphenyl)cyclohexa-3,5-diene-1,2-dione
4,5-dimethoxy-3,6-bis(4-methoxyphenyl)cyclohexa-3,5-diene-1,2-dione
(2s)-4-hydroxy-6-methoxy-7-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(2s)-4-hydroxy-6-methoxy-7-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(15e)-6-hydroxy-3-methoxy-12-methyl-15-(1-oxopropan-2-ylidene)-11-oxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,5,7,9,16-hexaene-5-carboxylic acid
(15e)-6-hydroxy-3-methoxy-12-methyl-15-(1-oxopropan-2-ylidene)-11-oxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1,3,5,7,9,16-hexaene-5-carboxylic acid
(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6s,7r,7as)-5,6,7-trihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1s,4ar,5s,6s,7r,7as)-5,6,7-trihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
4-{3,6,11,12-tetramethoxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-5-yl}phenol
4-{3,6,11,12-tetramethoxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaen-5-yl}phenol
3-(2h-1,3-benzodioxol-5-yl)-8-methoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
3-(2h-1,3-benzodioxol-5-yl)-8-methoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h,7h-[1,3]dioxolo[4,5-e]isoindol-8-one
6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h,7h-[1,3]dioxolo[4,5-e]isoindol-8-one
2-(hydroxymethyl)-6-{[5,6,7-trihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}oxane-3,4,5-triol
2-(hydroxymethyl)-6-{[5,6,7-trihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}oxane-3,4,5-triol
2-hydroxy-5-methoxy-3-(4-methoxyphenyl)-8,8-dimethylpyrano[3,2-g]chromen-4-one
2-hydroxy-5-methoxy-3-(4-methoxyphenyl)-8,8-dimethylpyrano[3,2-g]chromen-4-one
(2r)-5-hydroxy-4-methoxy-6-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
(2r)-5-hydroxy-4-methoxy-6-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
(2r,3s,4r,5r,6s)-6-{[(4ar,7r,7ar)-4a,7-dihydroxy-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-2-(dihydroxymethyl)-3-methyloxane-2,3,4,5-tetrol
(2r,3s,4r,5r,6s)-6-{[(4ar,7r,7ar)-4a,7-dihydroxy-1h,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl]oxy}-2-(dihydroxymethyl)-3-methyloxane-2,3,4,5-tetrol
5,6,7-trimethoxy-4-(4-methoxyphenyl)-3h-naphtho[2,3-d]imidazol-2-ol
5,6,7-trimethoxy-4-(4-methoxyphenyl)-3h-naphtho[2,3-d]imidazol-2-ol
(4s,4ar,5s,8r,8as)-4,8-dihydroxy-4a,5,8,8a-tetrahydro-4h-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-5-yl acetate
(4s,4ar,5s,8r,8as)-4,8-dihydroxy-4a,5,8,8a-tetrahydro-4h-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-5-yl acetate
6-[2-(5-hydroxy-5-methylhexyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboxylic acid
6-[2-(5-hydroxy-5-methylhexyl)-1,3-thiazol-4-yl]-4,5-dimethoxypyridine-2-carboxylic acid
(1r,2s,3r,6r)-1-[(benzoyloxy)methyl]-2-methoxy-7-oxabicyclo[4.1.0]hept-4-en-3-yl benzoate
(1r,2s,3r,6r)-1-[(benzoyloxy)methyl]-2-methoxy-7-oxabicyclo[4.1.0]hept-4-en-3-yl benzoate
15-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁵.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-triene-16,18-dione
15-hydroxy-8,10-dioxa-13,19-diazaoctacyclo[12.8.2.1¹,¹⁵.0²,¹⁹.0³,¹⁴.0³,¹⁷.0⁴,¹².0⁷,¹¹]pentacosa-4,6,11-triene-16,18-dione
(2s,3r,3ar,6as)-2-[(s)-hydroxy(phenyl)methyl]-5-oxo-tetrahydro-2h-furo[3,2-b]furan-3-yl (2e)-3-phenylprop-2-enoate
(2s,3r,3ar,6as)-2-[(s)-hydroxy(phenyl)methyl]-5-oxo-tetrahydro-2h-furo[3,2-b]furan-3-yl (2e)-3-phenylprop-2-enoate
(6e)-6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h-[1,3]dioxolo[4,5-e]isoindol-8-ol
(6e)-6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h-[1,3]dioxolo[4,5-e]isoindol-8-ol
(2s,3r,4r)-4-(2,4-dihydroxy-6-methylphenyl)-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
(2s,3r,4r)-4-(2,4-dihydroxy-6-methylphenyl)-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,7-diol
(2r)-7-(4-hydroxyphenyl)-4,6-dimethoxy-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(2r)-7-(4-hydroxyphenyl)-4,6-dimethoxy-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(6z)-6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h-[1,3]dioxolo[4,5-e]isoindol-8-ol
(6z)-6-({6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}methylidene)-2h-[1,3]dioxolo[4,5-e]isoindol-8-ol
(4s,4as,4br,8s,8as,10as)-8a-(bromomethyl)-4-hydroxy-8-isopropyl-4,10a-dimethyl-4a,4b,7,8,9,10-hexahydrophenanthren-3-one
(4s,4as,4br,8s,8as,10as)-8a-(bromomethyl)-4-hydroxy-8-isopropyl-4,10a-dimethyl-4a,4b,7,8,9,10-hexahydrophenanthren-3-one
(2r,3s,4s,5s,6r)-2-{[(1s,4as,5s,6s,7s,7as)-5,6,7-trihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3s,4s,5s,6r)-2-{[(1s,4as,5s,6s,7s,7as)-5,6,7-trihydroxy-7-(hydroxymethyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
5-hydroxy-4-methoxy-6-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
5-hydroxy-4-methoxy-6-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-7-one
4-hydroxy-6-methoxy-7-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
4-hydroxy-6-methoxy-7-(4-methoxyphenyl)-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
2-(4-hydroxyphenyl)-3,6-dimethoxy-8,8-dimethylpyrano[2,3-h]chromen-4-one
2-(4-hydroxyphenyl)-3,6-dimethoxy-8,8-dimethylpyrano[2,3-h]chromen-4-one
2-(2h-1,3-benzodioxol-5-yl)-5-methoxy-8,8-dimethyl-2h,3h-pyrano[2,3-f]chromen-4-one
2-(2h-1,3-benzodioxol-5-yl)-5-methoxy-8,8-dimethyl-2h,3h-pyrano[2,3-f]chromen-4-one
1-(2h-1,3-benzodioxol-5-yl)-3-(5-methoxy-2,2-dimethylchromen-6-yl)propane-1,3-dione
1-(2h-1,3-benzodioxol-5-yl)-3-(5-methoxy-2,2-dimethylchromen-6-yl)propane-1,3-dione
